SILVER SPRING, Md., July 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic:
Today, the Food and Drug Administration (FDA) updated its Frequently Asked Questions on Testing for SARS-CoV-2. The revised FAQs now include a list of laboratories that have been removed from the list of laboratories that had notified FDA that they had developed and validated diagnostic tests as set forth in Section IV.A of the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) ? titled "Laboratories Certified under CLIA that Meet the CLIA Regulatory Requirements to Perform High Complexity Testing Using Their Validated Diagnostic Tests Prior to EUA Submission." Any laboratory on this list has been removed from the notification list because FDA has determined that there are significant problems with its test that cannot be, or have not been, addressed in a timely manner and should no longer be used.
Testing updates:
To date, the FDA has currently authorized 179 tests under EUAs; these include 148 molecular tests, 29 antibody tests, and 2 antigen tests.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.
Anodot publishes its annual Cloud Cost Optimization Report, delivering insights from customer data and analysis of news and trends within the FinOps sector to prepare cloud users for 2024....
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...
Phenom today announced IAMPHENOM ? the human resources event for talent acquisition, talent management, CHROs, HRIS and executives ? has sold out with record-breaking registrations and is reaching maximum capacity. Waitlisting is now available.
The...
Sony Electronics Inc. today announced a new addition to its line of car AV receivers, the XAV-AX3700. The XAV-AX3700 includes a customizable experience to fit user's personal viewing preference, while providing optimal sound. This new model includes...
TransAlta Corporation ("TransAlta" or the "Company") announced today that it has signed onto a voluntary water-sharing memorandum of understanding ("MOU") with over thirty other water licence holders in the Bow River Basin. Water-sharing MOUs have...
Wipro Limited , a leading technology services and consulting company, announced financial results under International Financial Reporting Standards (IFRS) for the quarter and year ended March 31, 2024.
Highlights of the Results
Results for the...